Where does EBAC stock trade?

European Biotech Acquisition Corp. (EBAC) is listed on NASDAQ.

What sector and industry is EBAC in?

European Biotech Acquisition Corp. operates in the Finance sector, Blank Checks industry.

When did European Biotech Acquisition Corp. go public?

European Biotech Acquisition Corp. (EBAC) completed its IPO in 2021.

What companies are similar to EBAC?

Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare EBAC side-by-side with any of them on Quantisnow.

How can I track EBAC on Quantisnow?

Quantisnow aggregates European Biotech Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EBAC to receive live email and push alerts on every new disclosure.

EBAC

NASDAQ

European Biotech Acquisition Corp.

SectorFinanceIndustryBlank ChecksIPO2021

Follow Website

News25/Ratings0

European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Latest news

25 items

1182dSEC
SEC Form 15-12G filed by European Biotech Acquisition Corp.
15-12G - European Biotech Acquisition Corp. (0001841258) (Filer)
1193dSEC
SEC Form 25-NSE/A filed by European Biotech Acquisition Corp. (Amendment)
25-NSE/A - European Biotech Acquisition Corp. (0001841258) (Subject)
1195dSEC
European Biotech Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
8-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1196dSEC
SEC Form 10-K filed by European Biotech Acquisition Corp.
10-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1202dSEC
European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1209dSEC
SEC Form DEFA14A filed by European Biotech Acquisition Corp.
DEFA14A - European Biotech Acquisition Corp. (0001841258) (Filer)
1210d13D/G
SEC Form SC 13G filed by European Biotech Acquisition Corp.
SC 13G - European Biotech Acquisition Corp. (0001841258) (Subject)
1210dSEC
European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1210d13D/G
SEC Form SC 13G filed by European Biotech Acquisition Corp.
SC 13G - European Biotech Acquisition Corp. (0001841258) (Subject)
1217d13D/G
SEC Form SC 13G/A filed by European Biotech Acquisition Corp. (Amendment)
SC 13G/A - European Biotech Acquisition Corp. (0001841258) (Subject)
1220dSEC
SEC Form DEFM14A filed by European Biotech Acquisition Corp.
DEFM14A - European Biotech Acquisition Corp. (0001841258) (Filer)
1225dSEC
SEC Form 425 filed by European Biotech Acquisition Corp.
425 - European Biotech Acquisition Corp. (0001841258) (Subject)
1225dSEC
European Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1272dSEC
SEC Form 425 filed by European Biotech Acquisition Corp.
425 - European Biotech Acquisition Corp. (0001841258) (Subject)
1272dSEC
European Biotech Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1301dSEC
SEC Form 10-Q filed by European Biotech Acquisition Corp.
10-Q - European Biotech Acquisition Corp. (0001841258) (Filer)
1330dSEC
European Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1330dNEWS
Oculis SA And European Biotech Acquisition Corp Announce Business Combination Agreement To Create Nasdaq-lListed BioPharmaceutical Company Driving Breakthrough Innovations In Ophthalmology
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology Oculis is focused on becoming a leading global ophthalmic biopharmaceutical company with product candidates to address areas of significant medical needs, including diabetic macular edema (DME), dry eye disease (DED), and neuro-retina indications such as glaucoma, affecting growing patient populations Net proceeds expected to support advanced clinical pipeline of multiple innovative product candidates with near term potential value catalysts, potentially including the first topical eye-drop for DME, the
1330dPR
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology
Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology Oculis is focused on becoming a leading global ophthalmic biopharmaceutical company with product candidates to address areas of significant medical needs, including diabetic macular edema (DME), dry eye disease (DED), and neuro-retina indications such as glaucoma, affecting growing patient populationsNet proceeds expected to support advanced clinical pipeline of multiple innovative product candidates with near term potential value catalysts, potentially including the first topical eye-drop for DME, the fir
1392dSEC
SEC Form 10-Q filed by European Biotech Acquisition Corp.
10-Q - European Biotech Acquisition Corp. (0001841258) (Filer)
1483dSEC
SEC Form 10-Q filed by European Biotech Acquisition Corp.
10-Q - European Biotech Acquisition Corp. (0001841258) (Filer)
1529dSEC
SEC Form 10-K filed by European Biotech Acquisition Corp.
10-K - European Biotech Acquisition Corp. (0001841258) (Filer)
1575d13D/G
SEC Form SC 13G/A filed by European Biotech Acquisition Corp. (Amendment)
SC 13G/A - European Biotech Acquisition Corp. (0001841258) (Subject)
1580d13D/G
SEC Form SC 13G filed by European Biotech Acquisition Corp.
SC 13G - European Biotech Acquisition Corp. (0001841258) (Subject)
1592d13D/G
SEC Form SC 13G/A filed by European Biotech Acquisition Corp. (Amendment)
SC 13G/A - European Biotech Acquisition Corp. (0001841258) (Subject)

EBAC FAQ

6 questions

What does European Biotech Acquisition Corp. do?
European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Where does EBAC stock trade?
European Biotech Acquisition Corp. (EBAC) is listed on NASDAQ.
What sector and industry is EBAC in?
European Biotech Acquisition Corp. operates in the Finance sector, Blank Checks industry.
When did European Biotech Acquisition Corp. go public?
European Biotech Acquisition Corp. (EBAC) completed its IPO in 2021.
What companies are similar to EBAC?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare EBAC side-by-side with any of them on Quantisnow.
How can I track EBAC on Quantisnow?
Quantisnow aggregates European Biotech Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EBAC to receive live email and push alerts on every new disclosure.